Covers laboratory techniques and analytical instrumentation for drug discovery, including DNA, chromatography, cell culture, protein analysis, and mass spectrometry.
Recent recorded grades — Spring 2024: 3.89 GPA, 92.9% A/AB (n=14 letter grades); Spring 2025: 3.95 GPA, 100.0% A/AB (n=10 letter grades); Spring 2026: 3.88 GPA, 91.7% A/AB (n=12 letter grades). Includes jointly taught sections.
Recent recorded grades — Spring 2025: 3.86 GPA, 93.1% A/AB (n=29 letter grades); Fall 2025: 3.63 GPA, 89.5% A/AB (n=19 letter grades); Spring 2026: 3.85 GPA, 92.3% A/AB (n=26 letter grades).
Overview of drug development from discovery to IND, covering target identification, validation, hit-to-lead, CMC, pharmacology, pharmacokinetics, and toxicology for small and large molecules.
Recent recorded grades — Fall 2024: 3.44 GPA, 67.7% A/AB (n=31 letter grades); Fall 2025: 3.39 GPA, 78.3% A/AB (n=23 letter grades); Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades). Includes jointly taught sections.
Overview of drug development from first-in-human to NDA/BLA submission, covering clinical phases, biomarkers, companion diagnostics, statistical analysis, CMC, and both small molecule and protein therapeutics.
Recent recorded grades — Fall 2024: 3.89 GPA, 100.0% A/AB (n=9 letter grades); Spring 2025: 3.75 GPA, 92.9% A/AB (n=28 letter grades); Spring 2026: 3.93 GPA, 100.0% A/AB (n=27 letter grades).